CHEMICAL/BIOLOGICAL DEFENSE (EMD)

Abstract

The projects in this program element (PE) support the development, build, and test of products to verify that all operational and derived requirements have been met, and to support production or deployment decisions. The activities include mature system development, integration, and demonstration to support Milestone C decisions, and conducting operational test and evaluation of production representative articles. Individual projects include: - Contamination Avoidance (CA5): system development of reconnaissance, detection, identification, and warning systems that minimize chemical, biological, and radiological (CBR) contamination and prevent further cross-contamination during operations. - Homeland Defense (CM5): system development of common analytical laboratory system capabilities to conduct on-site analysis of any unknown sample and test potential life-threatening substances. - Collective Protection. (CO5): system development of collectively protected systems that are smaller, lighter, less costly to produce and maintain, and more logistically supportable enabling mission accomplishment in spaces safe from the effects of CBR contamination. - Decontamination (DE5): system development of Contamination Mitigation (ConMit) systems utilizing solutions that will remove/eliminate and/or detoxify contaminated material without damaging combat equipment, personnel, or the environment. - Individual Protection (IP5): system development of the next generation protective ensembles (e.g., suits, boots, and gloves) and respiratory and ocular protection equipment (e.g., protective masks) which enable the Joint Force to operate in a contaminated CBR environment with little or no degradation to his/her performance. - Information Systems (IS5): system development of information architectures, applications, and cybersecurity hardening for shaping the battlespace against CBR threats. - Medical Biological Defense (MB5): product development of medical biological countermeasure platform technologies, medical biological countermeasures (vaccines and therapeutics), reagents, assays, and diagnostic equipment to provide an effective capability for medical defense against biological warfare agent threats facing U.S. Forces in the field. - Medical Chemical Defense (MC5): product development of medical materiel and other medical equipment items (e.g., diagnostic equipment, prophylactic, pre-treatment, and therapeutic drugs, and individual/casualty decontamination compounds) necessary to provide an effective capability for medical defense against chemical warfare agent threats facing U.S. Forces in the field. - Test and Evaluation (TE5): critical test capabilities, planning, and infrastructure improvements/modifications necessary to evaluate CBRN Defense systems in realistic operating environments. The projects in this PE support the engineering and manufacturing development phase of the Department of Defense (DoD) acquisition system and are therefore correctly placed in Budget Activity 5.

Open PDF

Document Details

Document Type
R2 Budgetary Justification
Publication Date
Oct 01, 2021
Source ID
0604384BP_5_0400_PB_2021
Change Summary Explanation
Funding: FY19 (-$4.750 Million): Reprogrammings to (-$2.750 Million) support CBDP Defense Finance and Accounting System transactions and Financial Improvement & Audit Readiness and (-$2.000 Million) align filtration systems efforts to advanced technology development. FY19 (-$9.113 Million): Transfer of funding to support Small Business Innovative Research/Small Business Technology Transfer efforts. FY20 (+$11.000 Million): Congressional Add for Smallpox antiviral post-exposure prophylaxis. FY20 (-$10.000 Million): Congressional Directed Reductions to the Mounted Manned Platform Radiological Detection System, the Common Analytical Laboratory System, the Software Support Activity and other system development & demonstration programs. FY21 (+$26.950 Million): The FY21 funding request was reduced during the Defense-Wide Review (DWR) to account for programs being terminated or restructured (-$80.081 Million); Departmental economic adjustments (-$0.281 Million); and program increases to mitigate risk in the areas of detection, protection and hazard mitigation; to chemical agent detection and biological detection programs, next generation diagnostic programs, and protection programs (+$107.312 Million). Schedule: N/A Technical: Provides for critical new start program Forward Area Mobility Spray - System (FAMS-S).
Service Agency Name
Chemical and Biological Defense Program

Tags

Communities of Interest

  • Biomedical
  • Ground and Sea Platforms
  • Human Systems
  • Space

DTIC Thesaurus Topics

  • Agile Software Development
  • Air Force
  • Aircraft Equipment
  • Biological Factors
  • Chemical Agent Detection
  • Chemical Warfare
  • Chemical Warfare Agents
  • Data Analysis
  • Detection
  • Detectors
  • Information Systems
  • Medical Personnel
  • Systems Engineering
  • Test And Evaluation
  • Virus Diseases
  • Warfare
  • Warning Systems

Readers

  • Critical Infrastructure Protection in CBRN and WMD Threats.

Technology Areas

  • Biotechnology
  • Cyber
  • Space

Related Documents